drugset
Drugs / Efungumab
last change Nov 2007 re-read 2 minutes ago

Efungumab

also known as Mycograb · HSP-90MAB · MYC-123 · MYC-123A · MYC-123A MYC-123B MYC-124 HSP90MAB · MYC-123B · MYC-124

Monoclonal antibody

Developed for
Cryptococcal meningitis · breast cancer
Investigated by
Novartis Pharmaceuticals · NeuTec Pharma

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Refused (EMA) EU (EMA) Mycograb — 2007-05-22 europa.eu ↗

Trials 3 · a red edge is where a trial was stopped

today NCT00324025 · Ph 2 NCT00847678 · Ph 2 NCT00217815 · Ph 1/2
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT00217815 Sep 2005 → Oct 2006 breast cancer NeuTec Pharma Completed No outcome recorded
Phase 22 trials
Phase 2 NCT00324025 Mar → Sep 2007 Cryptococcal meningitis Novartis Pharmaceuticals Terminated No outcome recorded
Phase 2 NCT00847678 Aug 2006 → Nov 2007 Cryptococcal meningitis Novartis Pharmaceuticals Terminated No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Efungumab ClinicalTrials.gov intervention name — accepted as the source's own label NCT00847678 ↗
Known as HSP-90MAB ChEMBL registry synonym — accepted as the source's own label CHEMBL1743009 ↗
Known as MYC-123 ChEMBL registry synonym — accepted as the source's own label CHEMBL1743009 ↗
Known as MYC-123A ChEMBL registry synonym — accepted as the source's own label CHEMBL1743009 ↗
Known as MYC-123A MYC-123B MYC-124 HSP90MAB ChEMBL registry synonym — accepted as the source's own label CHEMBL1743009 ↗
Known as MYC-123B ChEMBL registry synonym — accepted as the source's own label CHEMBL1743009 ↗
Known as MYC-124 ChEMBL registry synonym — accepted as the source's own label CHEMBL1743009 ↗
Known as Mycograb “Biological: Efungumab (Mycograb)” NCT00847678 ↗
2

NCT00324025 ↗

NCT00217815 ↗
Action Inhibit “Mycograb® binds to hsp90, inhibiting hsp90 chaperone functioning” NCT00217815 ↗
Modality Monoclonal antibody — CHEMBL1743009 ↗
Route Intravenous “Mycograb Administered IV” NCT00217815 ↗